Vitrolife AB (publ) (FRA:VTFN)
Germany · Delayed Price · Currency is EUR 12.47
0.00 (0.00%)
Last updated: Jul 30, 2025
Vitrolife AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 3,541 | 3,609 | 3,512 | 3,234 | 1,681 | 1,246 | Upgrade | |
Revenue Growth (YoY) | 0.17% | 2.76% | 8.60% | 92.38% | 34.96% | -15.85% | Upgrade |
Cost of Revenue | 1,457 | 1,470 | 1,534 | 1,454 | 635 | 477.91 | Upgrade |
Gross Profit | 2,084 | 2,139 | 1,978 | 1,780 | 1,046 | 767.67 | Upgrade |
Selling, General & Admin | 1,262 | 1,232 | 1,117 | 1,002 | 503 | 311.35 | Upgrade |
Research & Development | 113 | 117 | 127 | 143 | 114 | 91.76 | Upgrade |
Other Operating Expenses | 14 | -1 | -4 | -12 | - | -2.55 | Upgrade |
Operating Expenses | 1,389 | 1,348 | 1,240 | 1,133 | 617 | 400.56 | Upgrade |
Operating Income | 695 | 791 | 738 | 647 | 429 | 367.11 | Upgrade |
Interest Expense | -98 | -98 | -94 | -44 | -10 | -2.09 | Upgrade |
Interest & Investment Income | 24 | 24 | 16 | 2 | 1 | 0.76 | Upgrade |
Currency Exchange Gain (Loss) | -30 | -30 | -64 | -34 | 41 | -16.79 | Upgrade |
Other Non Operating Income (Expenses) | 23 | -10 | -5 | -16 | -1 | -0.37 | Upgrade |
EBT Excluding Unusual Items | 614 | 677 | 591 | 555 | 460 | 348.62 | Upgrade |
Impairment of Goodwill | - | - | -4,250 | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 8.92 | Upgrade |
Gain (Loss) on Sale of Assets | -4 | -4 | -3 | -23 | - | -0.05 | Upgrade |
Asset Writedown | - | - | -50 | - | - | - | Upgrade |
Other Unusual Items | - | - | - | - | - | 8.7 | Upgrade |
Pretax Income | 611 | 674 | -3,712 | 537 | 460 | 366.19 | Upgrade |
Income Tax Expense | 156 | 160 | 139 | 143 | 116 | 78.33 | Upgrade |
Earnings From Continuing Operations | 455 | 514 | -3,851 | 394 | 344 | 287.87 | Upgrade |
Minority Interest in Earnings | - | -1 | - | - | -3 | -1.02 | Upgrade |
Net Income | 455 | 513 | -3,851 | 394 | 341 | 286.85 | Upgrade |
Net Income to Common | 455 | 513 | -3,851 | 394 | 341 | 286.85 | Upgrade |
Net Income Growth | - | - | - | 15.54% | 18.88% | -25.06% | Upgrade |
Shares Outstanding (Basic) | 135 | 135 | 135 | 135 | 115 | 109 | Upgrade |
Shares Outstanding (Diluted) | 136 | 136 | 135 | 135 | 115 | 109 | Upgrade |
Shares Change (YoY) | 0.10% | 0.09% | - | 18.12% | 5.60% | - | Upgrade |
EPS (Basic) | 3.36 | 3.79 | -28.44 | 2.91 | 2.97 | 2.64 | Upgrade |
EPS (Diluted) | 3.35 | 3.78 | -28.44 | 2.91 | 2.97 | 2.64 | Upgrade |
EPS Growth | - | - | - | -2.18% | 12.58% | -25.06% | Upgrade |
Free Cash Flow | 539 | 815 | 690 | 585 | 359 | 349.68 | Upgrade |
Free Cash Flow Per Share | 3.98 | 6.01 | 5.10 | 4.32 | 3.13 | 3.22 | Upgrade |
Dividend Per Share | 1.100 | 1.100 | 1.000 | 0.850 | 0.800 | 0.800 | Upgrade |
Dividend Growth | 10.00% | 10.00% | 17.65% | 6.25% | - | - | Upgrade |
Gross Margin | 58.85% | 59.27% | 56.32% | 55.04% | 62.22% | 61.63% | Upgrade |
Operating Margin | 19.63% | 21.92% | 21.01% | 20.01% | 25.52% | 29.47% | Upgrade |
Profit Margin | 12.85% | 14.21% | -109.65% | 12.18% | 20.29% | 23.03% | Upgrade |
Free Cash Flow Margin | 15.22% | 22.58% | 19.65% | 18.09% | 21.36% | 28.07% | Upgrade |
EBITDA | 1,073 | 1,167 | 1,107 | 991 | 506 | 420.88 | Upgrade |
EBITDA Margin | 30.30% | 32.34% | 31.52% | 30.64% | 30.10% | 33.79% | Upgrade |
D&A For EBITDA | 378 | 376 | 369 | 344 | 77 | 53.77 | Upgrade |
EBIT | 695 | 791 | 738 | 647 | 429 | 367.11 | Upgrade |
EBIT Margin | 19.63% | 21.92% | 21.01% | 20.01% | 25.52% | 29.47% | Upgrade |
Effective Tax Rate | 25.53% | 23.74% | - | 26.63% | 25.22% | 21.39% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.